Genetic Risk Prediction for Prostate Cancer: Implications for Early Detection and Prevention

被引:30
作者
Seibert, Tyler M. [1 ]
Garraway, Isla P. [2 ]
Plym, Anna [3 ]
Mahal, Brandon A. [4 ]
Giri, Veda [5 ]
Jacobs, Michelle F. [6 ]
Cheng, Heather H. [7 ]
Loeb, Stacy [8 ]
Helfand, Brian T. [9 ]
Eeles, Rosalind A. [10 ]
Morgan, Todd M. [6 ]
机构
[1] Univ Calif San Diego, La Jolla, CA USA
[2] Univ Calif Los Angeles, Los Angeles, CA USA
[3] Harvard TH Chan Sch Publ Hlth, Boston, MA USA
[4] Univ Miami, Miami, FL USA
[5] Yale Univ, New Haven, CT USA
[6] Univ Michigan, Ann Arbor, MI USA
[7] Univ Washington, Seattle, WA USA
[8] NYU, New York, NY USA
[9] NorthShore Univ HealthSyst, Evanston, IL USA
[10] Inst Canc Res, London, England
关键词
Ancestry; Disparities; Early detection; Genetics; Genomics; Lifestyle; Prevention; Prostate cancer; Race; Screening; POLYGENIC RISK; GERMLINE MUTATIONS; MEN; BRCA2; HETEROGENEITY; MORTALITY; SURVIVAL; BREAST; HOXB13; SCORE;
D O I
10.1016/j.eururo.2022.12.021
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Context: Prostate cancer (PCa) is a leading cause of death and partially heritable. Genetic risk prediction might be useful for strategies to reduce PCa mortality through early detection and prevention.Objective: To review evidence for genetic risk prediction for PCa. Evidence acquisition: A collaborative literature review was conducted using PubMed and Google Scholar. Search terms included genetic, risk, prediction, and "prostate cancer". Articles addressing screening, early detection, or prevention were prioritized, as were studies involving diverse populations.Evidence synthesis: Rare pathogenic mutations (RPMs), especially in DNA damage repair genes, increase PCa risk. RPMs in BRCA2 are most clearly deleterious, conferring 2-8.6 times higher risk of PCa and a higher risk of aggressive disease. Common genetic variants can be combined into genetic risk scores (GRSs). A high GRS (top 20-25% of the popula-tion) confers two to three times higher risk of PCa than average; a very high GRS (top 1- 5%) confers six to eight times higher risk. GRSs are not specific for aggressive PCa, pos-sibly due to methodological limitations and/or a field effect of an elevated risk for both low-and high-grade PCa. It is challenging to disentangle genetics from structural racism and social determinants of health to understand PCa racial disparities. GRSs are indepen-dently associated with a lethal PCa risk after accounting for family history and race/ ancestry. Healthy lifestyle might partially mitigate the risk of lethal PCa.Conclusions: Genetic risk assessment is becoming more common; implementation stud-ies are needed to understand the implications and to avoid exacerbating healthcare dis-parities. Men with a high genetic risk of PCa can reasonably be encouraged to adhere to a healthy lifestyle.Patient summary: Prostate cancer risk is inherited through rare mutations and through the combination of hundreds of common genetic markers. Some men with a high genetic
引用
收藏
页码:241 / 248
页数:8
相关论文
共 75 条
[1]   Germline genetic variation in prostate susceptibility does not predict outcomes in the chemoprevention trials PCPT and SELECT [J].
Ahmed, Mahbubl ;
Goh, Chee ;
Saunders, Edward ;
Cieza-Borrella, Clara ;
Kote-Jarai, Zsofia ;
Schumacher, Fredrick R. ;
Eeles, Ros .
PROSTATE CANCER AND PROSTATIC DISEASES, 2020, 23 (02) :333-342
[2]   Multifocal prostate cancer: biologic, prognostic, and therapeutic implications [J].
Andreoiu, Matei ;
Cheng, Liang .
HUMAN PATHOLOGY, 2010, 41 (06) :781-793
[3]   Mortality Results from a Randomized Prostate-Cancer Screening Trial [J].
Andriole, Gerald L. ;
Grubb, Robert L., III ;
Buys, Saundra S. ;
Chia, David ;
Church, Timothy R. ;
Fouad, Mona N. ;
Gelmann, Edward P. ;
Kvale, Paul A. ;
Reding, Douglas J. ;
Weissfeld, Joel L. ;
Yokochi, Lance A. ;
Crawford, E. David ;
O'Brien, Barbara ;
Clapp, Jonathan D. ;
Rathmell, Joshua M. ;
Riley, Thomas L. ;
Hayes, Richard B. ;
Kramer, Barnett S. ;
Izmirlian, Grant ;
Miller, Anthony B. ;
Pinsky, Paul F. ;
Prorok, Philip C. ;
Gohagan, John K. ;
Berg, Christine D. .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (13) :1310-1319
[4]   A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes [J].
Antoniou, AC ;
Pharoah, PDP ;
McMullan, G ;
Day, NE ;
Stratton, MR ;
Peto, J ;
Ponder, BJ ;
Easton, DF .
BRITISH JOURNAL OF CANCER, 2002, 86 (01) :76-83
[5]   Heterogeneity of gleason grade in multifocal adenocarcinorna of the prostate [J].
Arora, R ;
Koch, MO ;
Eble, JN ;
Ulbright, TM ;
Li, L ;
Cheng, L .
CANCER, 2004, 100 (11) :2362-2366
[6]   Genetic Factors, Adherence to Healthy Lifestyle Behavior, and Risk of Invasive Breast Cancer Among Women in the UK Biobank [J].
Arthur, Rhonda S. ;
Wang, Tao ;
Xue, Xiaonan ;
Kamensky, Victor ;
Rohan, Thomas E. .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2020, 112 (09) :893-901
[7]   A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study [J].
Bancroft, Elizabeth K. ;
Page, Elizabeth C. ;
Brook, Mark N. ;
Thomas, Sarah ;
Taylor, Natalie ;
Pope, Jennifer ;
McHugh, Jana ;
Jones, Ann-Britt ;
Karlsson, Questa ;
Merson, Susan ;
Ong, Kai Ren ;
Hoffman, Jonathan ;
Huber, Camilla ;
Maehle, Lovise ;
Grindedal, Eli Marie ;
Stormorken, Astrid ;
Evans, D. Gareth ;
Rothwell, Jeanette ;
Lalloo, Fiona ;
Brady, Angela F. ;
Bartlett, Marion ;
Snape, Katie ;
Hanson, Helen ;
James, Paul ;
McKinley, Joanne ;
Mascarenhas, Lyon ;
Syngal, Sapna ;
Ukaegbu, Chinedu ;
Side, Lucy ;
Thomas, Tessy ;
Barwell, Julian ;
Teixeira, Manuel R. ;
Izatt, Louise ;
Suri, Mohnish ;
Macrae, Finlay A. ;
Poplawski, Nicola ;
Chen-Shtoyerman, Rakefet ;
Ahmed, Munaza ;
Musgrave, Hannah ;
Nicolai, Nicola ;
Greenhalgh, Lynn ;
Brewer, Carole ;
Pachter, Nicholas ;
Spigelman, Allan D. ;
Azzabi, Ashraf ;
Helfand, Brian T. ;
Halliday, Dorothy ;
Buys, Saundra ;
Cajal, Teresa Ramon Y. ;
Donaldson, Alan .
LANCET ONCOLOGY, 2021, 22 (11) :1618-1631
[8]  
Bostwick DG, 1998, CANCER, V83, P1995, DOI 10.1002/(SICI)1097-0142(19981101)83:9<1995::AID-CNCR16>3.0.CO
[9]  
2-2
[10]   Spatial genomic heterogeneity within localized, multifocal prostate cancer [J].
Boutros, Paul C. ;
Fraser, Michael ;
Harding, Nicholas J. ;
de Borja, Richard ;
Trudel, Dominique ;
Lalonde, Emilie ;
Meng, Alice ;
Hennings-Yeomans, Pablo H. ;
McPherson, Andrew ;
Sabelnykova, Veronica Y. ;
Zia, Amin ;
Fox, Natalie S. ;
Livingstone, Julie ;
Shiah, Yu-Jia ;
Wang, Jianxin ;
Beck, Timothy A. ;
Have, Cherry L. ;
Chong, Taryne ;
Sam, Michelle ;
Johns, Jeremy ;
Timms, Lee ;
Buchner, Nicholas ;
Wong, Ada ;
Watson, John D. ;
Simmons, Trent T. ;
P'ng, Christine ;
Zafarana, Gaetano ;
Nguyen, Francis ;
Luo, Xuemei ;
Chu, Kenneth C. ;
Prokopec, Stephenie D. ;
Sykes, Jenna ;
Dal Pra, Alan ;
Berlin, Alejandro ;
Brown, Andrew ;
Chan-Seng-Yue, Michelle A. ;
Yousif, Fouad ;
Denroche, Robert E. ;
Chong, Lauren C. ;
Chen, Gregory M. ;
Jung, Esther ;
Fung, Clement ;
Starmans, Maud H. W. ;
Chen, Hanbo ;
Govind, Shaylan K. ;
Hawley, James ;
D'Costa, Alister ;
Pintilie, Melania ;
Waggott, Daryl ;
Hach, Faraz .
NATURE GENETICS, 2015, 47 (07) :736-+